Non-fibrous Chitin Dressing for Cell Support and Drug Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing wound dressings, particularly those based on chitin and chitosan, face limitations in promoting healing, controlling bacterial growth, and maintaining a conducive environment for tissue regeneration, especially in slow-healing wounds and ulcerations, due to their fibrous structure and limited ability to support cell application and controlled drug release.

Innovation Solution

A non-fibrous active polymer layer made of chitin derivatives obtained through esterification with aliphatic and cyclic anhydrides, which provides a three-dimensional structure with controlled porosity, antibacterial properties, and the ability to bind and release antibiotics, promoting wound healing by stimulating cellular migration and tissue regeneration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If fibrous chitin-based dressings are used, then antibacterial properties and biocompatibility are provided, but the ability to support cell application and controlled drug release is limited

Engineering Contradiction:
Improveability to support cell application and controlled drug releaseVSAvoidfibrous structure limitations
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent changes the structural parameter of chitin dressings from fibrous to non-fibrous form, creating a matrix that can accommodate cells and controlled drug release mechanisms while maintaining the beneficial biological properties of chitin

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention combines chitin with other materials to create composite non-fibrous structures that integrate cell support capabilities and controlled drug release functionality, overcoming the limitations of pure fibrous chitin dressings

Inventive Principle:
Principle #40Composite materials

2Productivity

If traditional fibrous dressings are used, then basic wound coverage is provided, but accelerated healing and tissue regeneration are not effectively promoted

Engineering Contradiction:
Improvehealing speedVSAvoidstructure simplicity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent modifies the physical and chemical parameters of chitin dressings by converting them to non-fibrous form and incorporating additional functional components, thereby accelerating healing and tissue regeneration while maintaining structural simplicity

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If chitin and chitosan are used, then intrinsic antibacterial properties are provided, but controlled release of exogenous antibacterial factors is limited

Engineering Contradiction:
Improvecontrolled release capabilityVSAvoidantibacterial factor delivery
Core Design Contradiction:
Adaptability or versatilityVSQuantity of substance

Solution Approach 1:

The patent changes the structural parameters of chitin dressings to enable controlled release of exogenous antibacterial factors, creating a matrix that can deliver precise quantities of antibiotics while maintaining the intrinsic antibacterial properties of chitin

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The non-fibrous chitin matrix acts as an intermediary carrier that facilitates the controlled release of exogenous antibacterial factors, enhancing the overall antibacterial effect while allowing precise dosage control

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The non-fibrous chitin derivative dressings demonstrate enhanced healing properties, including accelerated skinning over, improved viability, and bonding force, while maintaining a conducive environment for wound healing and preventing infection, with the ability to support cell application and controlled drug release, outperforming traditional fibrous dressings in clinical and in vitro studies.

Implementation Method 1

Chitin and its derivatives have intrinsic antibacterial and antifungal properties. Cationic groups bound to anions of a bacterial cell wall may inhibit biosynthesis, moreover, chitin may disrupt molecular transport through a bacterial cell wall thus accelerating their death

Methodology Applied
Scientific EffectAntibacterial effect:

Implementation Method 2

Chitin and chitosan act as chemoattractants for macrophages or neutrophils, thus initiating healing processes, and stimulating granulating and re-epithelisation processes

Methodology Applied
Scientific EffectChemoattractant effect:

Implementation Method 3

Chitin derivatives (chitin polyesters) are obtained in a reaction of chitin esterification in a presence of relevant aliphatic and cyclic anhydrides, and certain hydroxy acids

Methodology Applied
Scientific EffectEsterification reaction:

Data Source

PatentUS9675729B2Active polymer layer made of chitin derivatives, especially for a dressing, and its use
Publication Date: 2017.06.13 CELTHER POLSKA
  • US9675729B2 patent drawing
  • US9675729B2 patent drawing
  • US9675729B2 patent drawing

AI summary

The invention refers to an active polymer layer (1) especially for a dressing of a three-dimensional structure characterized in that it has non-fibrous structure made of chitin derivatives obtained in the esterification reaction of chitin in the presence of aliphatic anhydrides of a chain of a length from C2 to C8 straight saturated, and anhydrides preferably, acetic-propionic anhydride, butanoic-propionic anhydride, branched unsaturated anhydrides preferably, methacrylic anhydride, 2-butenoic anhydride and cyclic preferably, maleic anhydride, succinic anhydride, phthalic anhydride) and hydroxyacids preferably, lactic acid, glycolic acid, which can comprise additionally fibroblasts (6) and/or keratinocytes (7) and is used for producing dressing which can be applied on affected areas, including clean, flat shallow ulcerations characterised by modifiable granulations, the patent femoral artery with mild and moderate deficiency and no intensive exudation.